Applied Molecular Transport to Present at Upcoming November Investor Conferences
09 November 2022 - 12:00AM
GlobeNewswire Inc.
Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a
clinical-stage biopharmaceutical company, today announced its
participation at the following investor conferences:
Event: Guggenheim 4th Annual
Immunology and Neurology DayFormat: Corporate
Presentation Date & Time: Monday,
November 14, 2022, at 9:35 a.m. ET Location: New
York, New YorkPresenter: Tahir Mahmood, Ph.D.,
chief executive officer and co-founder
Event: Jefferies London
Healthcare ConferenceFormat: Fireside Chat
Date & Time: Wednesday, November
16, 2022, at 1:30 p.m. GMT Location: London,
UKPresenters: Shawn Cross, president and chief
operating officer, and Bittoo Kanwar, M.D., chief medical
officer
Live webcasts will be accessible via the Events
page of the Applied Molecular Transport website at
https://ir.appliedmt.com/news-events/events. Archived replays will
be available for 30 days following the events.
About Applied Molecular Transport Inc.
AMT is a clinical-stage biopharmaceutical
company developing novel oral biologic product candidates, by
leveraging its technology platform to design biologic product
candidates in patient friendly oral dosage forms. AMT’s product
candidates are designed to precisely target the relevant
pathophysiology of disease. AMT’s proprietary technology platform
is incorporated in its product candidates, exploiting existing
natural cellular trafficking pathways to drive the active transport
of diverse therapeutic modalities across the IE barrier. Active
transport is an efficient mechanism that utilizes the cell’s own
machinery to transport materials across the IE barrier.
AMT’s headquarters, internal GMP manufacturing
and lab facilities are located in South San Francisco, CA. For
additional information on AMT, please visit www.appliedmt.com.
Investor Relations Contact:Andrew ChangHead,
Investor Relations & Corporate
Communicationsachang@appliedmt.com
Media Contacts:Alexandra SantosWheelhouse Life
Science Advisorsasantos@wheelhouselsa.com
Aljanae ReynoldsWheelhouse Life Science
Advisorsareynolds@wheelhouselsa.com
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Feb 2023 to Mar 2023
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Mar 2022 to Mar 2023